Novo Nordisk’s TV Ad Gets Slapped by FDA

The FDA just told Novo Nordisk to stop running its TV ad for an obesity pill, saying it’s full of ‘false or misleading’ claims. They’re giving the company an ultimatum: fix the ads or pull them altogether.

What’s Next for Novo Nordisk?

It’s not clear what Novo Nordisk will do, but they won’t have a choice if they want to keep advertising. The FDA’s warning is pretty clear: cease all ads with misleading claims about the pill. If they don’t comply, they’ll face the music.